ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Knockdown of FLOT1 Impairs Cell Proliferation and Tumorigenicity in Breast Cancer through Upregulation of FOXO3a

Lin Chuyong; Wu Zhiqiang; Lin Xi; Yu Chunping; Shi Tingting; Zeng Yong; Wang Xi; Li Jun; Song Libing*中山大学
Clinical Cancer Research2011-5-15DOI: 10.1158/1078-0432.CCR-10-3068
47被引5阅读
引用收藏
分享

摘要

Purpose: Lipid rafts, specialized domains in cell membranes, function as physical platforms for various molecules to coordinate a variety of signal transduction processes. Flotinllin-1 (FLOT1), a marker of lipid rafts, is involved in the progression of cancer, but the precise mechanism remains unclear. The aim of the present study was to examine the role of FLOT1 on the tumorigenesis of breast cancer cells and its clinical significance in progression of the disease. <br>Experimental Design: FLOT1 expression was analyzed in 212 paraffin-embedded, archived clinical breast cancer samples by using immunohistochemistry (IHC). The effect of FLOT1 on cell proliferation and tumorigenesis was examined in vitro and in vivo. Western blotting and luciferase reporter analyses were carried out to identify the effects of downregulating FLOT1 on expression of cell cycle regulators and transcriptional activity of FOXO3a. <br>Results: IHC analysis revealed high expression of FLOT1 in 129 of the 212 (60.8%) paraffin-embedded archived breast cancer specimens. The overall expression level of FLOT1 significantly correlated with clinical staging and poor patient survival of breast cancer. Strikingly, we found that silencing FLOT1 inhibited proliferation and tumorigenicity of breast cancer cells both in vitro and in vivo, which was further shown to be mechanistically associated with suppression of Akt activity, enhanced transcriptional activity of FOXO3a, upregulation of cyclin-dependent kinase inhibitor p21(Cip1) and p27(Kip1), and downregulation of the CDK regulator cyclin D1. <br>Conclusions: FLOT1 plays an important role in promoting proliferation and tumorigenesis of human breast cancer and may represent a novel prognostic biomarker and therapeutic target for the disease. Clin Cancer Res; 17(10); 3089-99.

相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Clinical Cancer Research
发表日期
2011-05-15
卷期
第 17 卷, 第 10 期
页码
3089-3099
DOI
10.1158/1078-0432.CCR-10-3068
语言
ENGLISH
成果收录
SCI
资助标注
Natural Science Foundation of China [81071780, 81030048, 30870963, 30831160517]; Program for New Century Excellent Talents in Universities [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [8251008901000006, 2008A030201006]; Ministry of Education of China [(2008)890, 200805580047, 20100171110080]; Fundamental Research Funds for the Central Universities [10ykzd03]

作者

  • L

    Lin Chuyong (第一作者)

  • W

    Wu Zhiqiang

查看全部 9 位作者收起作者
  • L

    Lin Xi

  • Y

    Yu Chunping

  • S

    Shi Tingting

  • Z

    Zeng Yong

  • W

    Wang Xi

  • L

    Li Jun

  • S

    Song Libing (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417